Bcv is a French Medtech startup specializing in developing innovative technologies for endovascular procedures. Founded in 2016 as a spin-off from the Intelligent Robotic Systems Laboratory (ISIR) at Sorbonne University and the Rothschild Foundation Hospital in Paris, Bcv's multidisciplinary team focuses on immediate improvement and future applications in the medical devices and robotics industries.
The company's flagship product is an actuable guidewire with electronically controllable shape-ability, specifically designed for use in interventional neuroradiology procedures to enhance endovascular access and navigation in any anatomy. The first-of-its-kind Shape Memory Alloy actuated system is suited for minimally invasive interventions, replacing traditional devices in a single solution. It features a unique smart handle allowing electronic actuation and controllable torque of the catheter tip robotically, making it ergonomic and compatible with Robotics and Image Guided Therapy.
Despite being an investigational device not yet available for commercial sale worldwide, Bcv reached a milestone with a €6.00M Series A investment on 13 December 2023. The investors in this round were Forepont Capital Partners, MEDCO Inter, NTI Corporation.
Headquartered in France, Bcv's groundbreaking technology has the potential to revolutionize endovascular minimally-invasive procedures, offering a game-changing solution for reaching the most complex parts of the human body.